Your browser doesn't support javascript.
loading
Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.
Yamasaki, Satoshi; Aoki, Jun; Mori, Jinichi; Mizuno, Shohei; Uchida, Naoyuki; Ohashi, Kazuki; Fukuda, Takahiro; Ikegame, Kazuhiro; Eto, Tetsuya; Ogawa, Yukiyasu; Tanaka, Masatsugu; Hidaka, Michihiro; Iwato, Koji; Sawa, Masashi; Ichinohe, Tatsuo; Kanda, Yoshinobu; Atsuta, Yoshiko; Yanada, Masamitsu; Yano, Shingo.
Afiliación
  • Yamasaki S; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan. yamas009@gmail.com.
  • Aoki J; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Mori J; Department of Hematology, Jyoban hospital, Iwaki, Japan.
  • Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
  • Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Fukuda T; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Ogawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Hidaka M; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Iwato K; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Atsuta Y; Department of Healthcare Administration, Nagoya University Graduate School of Medicine and Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Yano S; Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Bone Marrow Transplant ; 55(1): 249-252, 2020 01.
Article en En | MEDLINE | ID: mdl-30971777
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2020 Tipo del documento: Article País de afiliación: Japón